Table 2.
Types of underlying malignancies and chemotherapy regimens used
| Type of malignancy | Diagnosis | n | Chemotherapy regimen |
|---|---|---|---|
| Oncologic | Breast cancer | 24 | Anthracycline, cyclophosphamide, docetaxel |
| Colorectal cancer | 17 | Fluorouracil, oxaliplatin, irinotecan | |
| Stomach cancer | 16 | Fluorouracil, cisplatin, oxaliplatin, docetaxel, etoposide, irinotecan, paclitaxel | |
| Non-small cell lung cancer | 11 | Genexol, cisplatin, carboplatin, gemcitabine, vinorelbine, paclitaxel, fluorouracil | |
| Hepatocellular carcinoma | 5 | Fluorouracil, mitomycin, cisplatin, sorafenib | |
| Head and neck cancer | 3 | Docetaxel, fluorouracil, cisplatin, tegafur | |
| Cholangiocarcinoma | 3 | Gemcitabine, fluorouracil, irinotecan, cisplatin | |
| Brain tumor | 1 | Bleomycin, etoposide, cisplatin, temozolomide | |
| Osteosarcoma | 1 | Methotrexate, adriamycin, cisplatin | |
| Hematologic | Non-Hodgkin lymphoma | 20 | Rituximab, cyclophosphamide, vincristine, prednisolone, cytarabine, vinorelbine, carboplatin, bleomycin, procarbazine, adriamycin, mitoxantrone, melphalan, methotrexate, busulfan etoposide, daunorubicin, cisplatin |
| Leukemia | 8 | Cytarabine, idarubicin, melphalan, methotrexate, cyclophosphamide, mitoxantron, fludarabine, daunorubicin, vincristine, prednisolone, busulfan | |
| Multiple myeloma | 1 | Vincristine, adriamycin, dexamethasone, thalidomide |